subject: MarketsandMarkets: Global Biosimilars product market worth $19.4 billion by 2014 [print this page] The Biotech practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Biosimilar market to be held on 22 Sep 2009. The briefing on the Global Biosimilar Market (2009-2014) will benefit the Active pharmaceutical ingredients (APIs) manufacturers, contract research organizations, biosimilar drug manufacturers, medical/pharma associations, research labs, healthcare service providers, regulatory authorities, and technology providers.
MarketsandMarkets: Global Biosimilars product market worth $19.4 billion by 2014
By: Ms. Sunita
welcome to Insurances.net (https://www.insurances.net)
